Update on biologicals for treatment of juvenile idiopathic arthritis

FRI0326 Effectiveness and safety of etanercept in paediatric subjects with extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: The clipper study

(2014) G. Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

OP0055 IL-1 receptor antagonist restores IL-18 nk cell axis in systemic JIA

(2014) W. De Jager et al.   ANNALS OF THE RHEUMATIC DISEASES

FRI0337 Safety and efficacy of adalimumab in children with active polyarticular juvenile idiopathic arthritis aged 2 to

(2014) D. Kingsbury et al.   ANNALS OF THE RHEUMATIC DISEASES

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry

(2012) A. Klein et al.   ARTHRITIS CARE & RESEARCH

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

(2011) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis

(2011) Ekaterina I. Alexeeva et al.   CLINICAL RHEUMATOLOGY

Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

(2011) Marieke H. Otten et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept

(2011) T. D. van DIJKEN et al.   JOURNAL OF RHEUMATOLOGY

Interdisziplinäre S2-Therapieleitlinie der Juvenilen Idiopathischen Arthritis (2. Auflage)

(2011) G. Dueckers et al.   KLINISCHE PADIATRIE

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

(2010) N. Ruperto et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

(2010) P. Quartier et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

(2010) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study

(2010) J. F. Simard et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration

(2010) Peter Diak et al.   ARTHRITIS AND RHEUMATISM

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series

(2010) Peter A. Nigrovic et al.   ARTHRITIS AND RHEUMATISM

B cell depletion for autoimmune diseases in paediatric patients

(2010) Annette F. Jansson et al.   CLINICAL RHEUMATOLOGY

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

(2010) Randy Q Cron et al.   Pediatric Rheumatology

Report on malignancies in the German juvenile idiopathic arthritis registry

(2010) G. Horneff et al.   RHEUMATOLOGY

Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis

(2010) V. Papsdorf et al.   RHEUMATOLOGY

Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis

(2009) J Narvaez et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment strategies for juvenile idiopathic arthritis

(2009) Ariane Klein et al.   EXPERT OPINION ON PHARMACOTHERAPY

Rituximab Therapy Produced Rapid and Sustained Clinical Improvement in a Patient With Systemic Onset Juvenile Idiopathic Arthritis Refractory to TNF Alpha Antagonists

(2009) Julio García Feito et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Anakinra for Systemic Juvenile Arthritis

(2009) Andrew Zeft et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

(2009) Helen J. Lachmann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report

(2009) M. Kasher-Meron et al.   RHEUMATOLOGY

Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis

(2009) G. Horneff et al.   RHEUMATOLOGY

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Successful treatment of resistant pseudogout with anakinra

(2008) Dennis McGonagle et al.   ARTHRITIS AND RHEUMATISM

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

(2008) Jonathan Kay et al.   ARTHRITIS AND RHEUMATISM

The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

(2008) Marco Gattorno et al.   ARTHRITIS AND RHEUMATISM

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

(2008) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study

(2008) Norman Ilowite et al.   CLINICAL RHEUMATOLOGY

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

(2008) Shumpei Yokota et al.   LANCET

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

(2008) Nicolino Ruperto et al.   LANCET

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE